Equity
MethodX paid out €168,026 in dividends. That is 100% of the 2025 profit.
MethodX paid out €168,026 in dividends. That is 100% of the 2025 profit.
The micro format states no turnover.
Debts rose by €175,091 in 2025.
Short-term debts rose from €10,176 to €185,267.
The 2022 accounts came latest: 25 days after the end of the period.
Higher net result than 90% of companies in research and development. Sector median €27,659 · 620 companies.
The dashed line is the sector median: 0.1% across 932 companies (NACE 72, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 50% of them on solvency, 72% on liquidity, 90% on profitability and 46% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 3,127 companies had the same profile as MethodX has now. Each dot stands for 8 companies, two years later.
That fits the bankruptcy probability of MethodX itself: < 0.1% within 12 months.
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,127 companies, not a prediction for MethodX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Liquidity is ample, with a current ratio of 2.54 (28.26 in 2024), above the usual 1.5. Short-term debt is 36.4% and cash 50.1% of total assets. 42.2% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 4 accounts on average 31 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
| Company | ||||
|---|---|---|---|---|
| MethodX Waterloo | €509,257 | €255,617 | 57.8% | - |
| SETIS SYSTEMS Lochristi | €385,933 | €230,419 | 75.2% | 2.7 |
| TAKHIM FOR TECHNOLOGY AND BUSINESS SERVICES Wavre | €647,200 | €380,396 | 40.3% | - |
| BGTech project Jodoigne | €605,171 | €214,708 | 48.5% | - |
| Heart Rhythm Research Center Sint-Genesius-Rode | €483,417 | €138,973 | 62.5% | - |
| Dr. S. Beeckman - Dr. B. Van de Maele Oostkamp | €321,519 | €341,196 | 76.6% | - |
| CIVASEL Ciney | €530,784 | €275,420 | 72.8% | 2 |
These companies have the same main activity as MethodX: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €322,000 and €647,000, founded between 2020 and 2023.
MethodX files the micro format. That format states no turnover. The gross margin rose from €64,918 in 2022 to €255,617 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €510,000. Estimated: probably between €360,000 and €750,000.
Higher than 47% of 620 companies in 2025.
Higher than 48% of 580 companies in 2025.
Higher than 82% of 597 companies in 2025.
Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter
| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet: assets | |||||
20/58 |
509,257 | 333,187 | 223,550 | 79,092 | |
21/28 |
38,402 | 45,561 | - | - | |
22/27 |
38,402 | 45,561 | - | - | |
24 |
38,402 | 45,561 | - | - | |
29/58 |
470,856 | 287,626 | 223,550 | 79,092 | |
40/41 |
109,105 | 80,383 | 43,312 | 8,246 | |
40 |
36,246 | 36,072 | 35,019 | - | |
41 |
72,859 | 44,311 | 8,293 | 8,246 | |
50/53 |
99,914 | 100,000 | 50,000 | - | |
54/58 |
255,086 | 101,368 | 130,237 | 70,846 | |
490/1 |
6,750 | 5,874 | - | - | |
| Balance sheet: equity and liabilities | |||||
10/49 |
509,257 | 333,187 | 223,550 | 79,092 | |
10/15 |
294,164 | 294,164 | 175,761 | 56,607 | |
10/11 |
10,000 | 10,000 | 10,000 | 10,000 | |
13 |
284,164 | 284,164 | 165,761 | 46,607 | |
133 |
284,164 | 284,164 | 165,761 | 46,607 | |
16 |
29,826 | 28,846 | 29,415 | - | |
160/5 |
29,826 | 28,846 | 29,415 | - | |
164/5 |
29,826 | 28,846 | 29,415 | - | |
17/49 |
185,267 | 10,176 | 18,373 | 22,485 | |
42/48 |
185,267 | 10,176 | 18,089 | 22,485 | |
43 |
2,503 | - | - | - | |
430/8 |
2,503 | - | - | - | |
44 |
352 | 0 | 4,795 | - | |
440/4 |
352 | 0 | 4,795 | - | |
45 |
39,590 | 10,176 | 9,552 | 22,485 | |
450/3 |
39,590 | 10,176 | 9,552 | 22,485 | |
47/48 |
142,822 | - | 3,743 | - | |
492/3 |
- | - | 284 | - | |
| Income statement | |||||
9900 |
255,617 | 204,422 | 212,536 | 64,918 | |
630 |
10,813 | 4,870 | - | - | |
635/8 |
980 | -569 | 29,415 | - | |
640/8 |
197 | 138 | - | - | |
9901 |
243,628 | 199,983 | 183,121 | 64,918 | |
75/76B |
8,109 | 3,185 | - | - | |
75 |
8,109 | 3,185 | - | - | |
65/66B |
31,636 | 34,822 | 3,860 | 175 | |
65 |
31,636 | 34,822 | 3,860 | 113 | |
66B |
- | - | - | 62 | |
9903 |
220,100 | 168,346 | 179,261 | 64,743 | |
67/77 |
52,074 | 49,943 | 60,107 | 18,136 | |
9904 |
168,026 | 118,403 | 119,154 | 46,607 | |
9905 |
168,026 | 118,403 | 119,154 | 46,607 | |
| Appropriation of the result | |||||
9906 |
168,026 | 118,403 | 119,154 | 46,607 | |
691/2 |
- | 118,403 | 119,154 | 46,607 | |
6921 |
- | 118,403 | 119,154 | 46,607 | |
694/7 |
168,026 | - | - | - | |
694 |
168,026 | - | - | - | |
| Document | |||||
The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).
Source: Annual accounts 2025 (PDF), filed on 02-04-2026.
| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| 254,441 | 204,853 | - | - | ||
| 178,839 | 123,273 | - | - | ||
| 3,653 | 50,431 | - | - | ||
| 153,718 | -28,869 | 59,391 | - | ||
| 285,589 | 277,449 | 205,460 | 56,607 | ||
| 57.8% | 88.3% | 78.6% | 71.6% | ||
| 2.54 | 28.26 | 12.36 | 3.52 | ||
| 0.63 | 0.03 | 0.10 | 0.40 | ||
| 57.1% | 40.3% | 67.8% | 82.3% | ||
| 33.0% | 35.5% | 53.3% | 58.9% | ||
| 8.04 | 5.88 | - | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible fixed assets | €3,653 | €50,431 | - | - |
| €10,813 | €4,870 | - | - |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
The operating result for 2025 is 22% higher than in 2024 and the highest since 2022. It is the third rise in a row.
Debt's share of the balance-sheet total rises from 3.1% to 36.4%. Debt is higher.
MethodX has no parent and no holdings in its annual accounts. MethodX shares no director with another company.
Deadline for the 2026 accounts: 31-07-2027
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
| Establishment | Since | Unit number |
|---|---|---|
| Avenue du Zodiaque 88 registered office 1410 Waterloo 62100 Computer programming | 03-02-2022 | 2.327.665.250 |
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 25764O0152/00B000 | 758 m² | 1 · 138 m² | 7.5 m · 2 |
If something looks wrong or is missing, please tell us.